Who to call at Debiopharm, and when
Fundz watches for the moments Debiopharm starts buying, and tells you who to reach.
- An alert the day Debiopharm raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Debiopharm, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Debiopharm. With Fundz connected, it knows.
Contract Type
agreement
Description
Debiopharm has deployed Genialis Expressions software to enhance biomarker discovery and analytics. This agreement extends their multi-year collaboration, granting Debiopharm access to Genialis’ technology for better processing of omics data.
Quick answer
Debiopharm Partners with Genialis to Utilize AI Software for Biomarker Discovery. (January 11, 2026). Debiopharm is based in Lausanne, Vaud, Switzerland.
- What agreement did Debiopharm announce on January 11, 2026?
- Debiopharm has deployed Genialis Expressions software to enhance biomarker discovery and analytics. This agreement extends their multi-year collaboration, granting Debiopharm access to Genialis’ technology for better processing of omics data.
- What does Debiopharm do?
- Debiopharm is a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases.
- Where is Debiopharm based?
- Debiopharm is based in Lausanne, Vaud, Switzerland.
Source: Fundz verified event record.
Related People
Debiopharm signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.